Hanger, Inc. provides orthotic and prosthetic (O&P) services; and distributes O&P devices and components, manages O&P networks, and provides therapeutic solutions to patients and businesses in acute, post-acute, and clinic settings in the United States. It operates through two segments, Patient Care and Products & Services. The Patient Care segment owns and operates Hanger clinic, which specializes in the design, fabrication, and delivery of custom O&P devices through patient care clinics and satellite locations; and provides payor network contracting services to other O&P providers. The Products & Services segment procures and distributes O&P parts, componentry, and devices to independent O&P providers; and develops specialized rehabilitation technologies and provides evidence-based clinical programs for post-acute rehabilitation to patients at approximately 4,000 skilled nursing and post-acute providers. This segment also manufactures and sells therapeutic footwear for diabetic patients in the podiatric market. As of May 14, 2018, the company owned and operated approximately 800 patient care clinics in the United States. The company was formerly known as Hanger Orthopedic Group, Inc. and changed its name to Hanger, Inc. in June 2012. Hanger, Inc. was founded in 1861 and is headquartered in Austin, Texas.
Industry, Sector and Symbol
Industry Specialty outpatient clinics, not elsewhere classified
Sub-IndustryHealth Care Facilities
SectorMedical
Phone512-777-3800
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees4,600
Next Earnings Date3/14/2019 (Confirmed)
OptionableOptionable
Hanger (OTCMKTS:HNGR) Frequently Asked Questions
What is Hanger's stock symbol?
Hanger trades on the OTCMKTS under the ticker symbol "HNGR."
How were Hanger's earnings last quarter?
Hanger Inc (OTCMKTS:HNGR) announced its quarterly earnings results on Thursday, August, 9th. The healthcare company reported $0.28 EPS for the quarter, missing the Zacks' consensus estimate of $0.33 by $0.05. The healthcare company earned $266.97 million during the quarter, compared to analysts' expectations of $265.58 million. View Hanger's Earnings History.
When is Hanger's next earnings date?
Has Hanger been receiving favorable news coverage?
Press coverage about HNGR stock has been trending somewhat positive this week, InfoTrie Sentiment reports. The research group identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Hanger earned a media sentiment score of 1.7 on InfoTrie's scale. They also assigned media headlines about the healthcare company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the near term.
Who are some of Hanger's key competitors?
Some companies that are related to Hanger include Ultragenyx Pharmaceutical (RARE), GETINGE AB/ADR (GNGBY), Inogen (INGN), NuVasive (NUVA), Genomic Health (GHDX), The Ensign Group (ENSG), Enerplus (ERF), Immunomedics (IMMU), Tandem Diabetes Care (TNDM), ACADIA Pharmaceuticals (ACAD), Integer (ITGR), Intercept Pharmaceuticals (ICPT), China Biologic Products (CBPO), Quidel (QDEL) and HMS (HMSY).
What other stocks do shareholders of Hanger own?
Who are Hanger's key executives?
Hanger's management team includes the folowing people:
- Mr. Vinit K. Asar, CEO, Pres & Director (Age 52)
- Mr. Thomas E. Kiraly, CFO & Exec. VP (Age 58)
- Mr. Thomas E. Hartman, Sr. VP, Gen. Counsel & Sec. (Age 55)
- Mr. Samuel M. Liang, Pres of Hanger Clinic (Age 55)
- Ms. Gabrielle B. Adams, VP & Chief Accounting Officer (Age 49)
Who are Hanger's major shareholders?
Hanger's stock is owned by a number of of institutional and retail investors. Top institutional investors include Victory Capital Management Inc. (8.78%), Prosight Management LP (3.23%), Cannell Capital LLC (2.69%), SCW Capital Management LP (2.53%), Segall Bryant & Hamill LLC (1.47%) and Thompson Investment Management Inc. (1.46%). View Institutional Ownership Trends for Hanger.
Which institutional investors are selling Hanger stock?
HNGR stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Thompson Investment Management Inc., Dimensional Fund Advisors LP, Prosight Management LP, First Manhattan Co. and CenterStar Asset Management LLC. View Insider Buying and Selling for Hanger.
Which institutional investors are buying Hanger stock?
HNGR stock was acquired by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., SCW Capital Management LP, Geode Capital Management LLC, Cannell Capital LLC, Segall Bryant & Hamill LLC, BlackRock Inc., Northern Trust Corp and Acadian Asset Management LLC. View Insider Buying and Selling for Hanger.
How do I buy shares of Hanger?
Shares of HNGR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Hanger's stock price today?
One share of HNGR stock can currently be purchased for approximately $20.25.
How big of a company is Hanger?
Hanger has a market capitalization of $746.17 million. Hanger employs 4,600 workers across the globe.
What is Hanger's official website?
How can I contact Hanger?
Hanger's mailing address is 10910 DOMAIN DRIVE SUITE 300, AUSTIN TX, 78758. The healthcare company can be reached via phone at 512-777-3800 or via email at [email protected]
MarketBeat Community Rating for Hanger (OTCMKTS HNGR)
MarketBeat's community ratings are surveys of what our community members think about Hanger and other stocks. Vote "Outperform" if you believe HNGR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HNGR will underperform the S&P 500 over the long term. You may vote once every thirty days.
